X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6128) 6128
Book Chapter (17) 17
Dissertation (11) 11
Publication (6) 6
Conference Proceeding (3) 3
Book / eBook (2) 2
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3681) 3681
animals (2391) 2391
male (2211) 2211
neprilysin (2029) 2029
neprilysin - metabolism (1638) 1638
female (1600) 1600
neprilysin - antagonists & inhibitors (1305) 1305
middle aged (992) 992
rats (947) 947
adult (890) 890
aged (809) 809
neutral endopeptidase (760) 760
immunohistochemistry (729) 729
mice (685) 685
pathology (617) 617
heart failure (615) 615
neprilysin - analysis (610) 610
pharmacology & pharmacy (589) 589
cardiac & cardiovascular systems (556) 556
expression (547) 547
neprilysin - genetics (540) 540
biochemistry & molecular biology (535) 535
neurosciences (456) 456
alzheimer's disease (419) 419
cd10 (409) 409
aged, 80 and over (360) 360
angiotensin-converting enzyme (356) 356
heart failure - drug therapy (352) 352
molecular sequence data (339) 339
oncology (336) 336
prognosis (336) 336
protease inhibitors - pharmacology (335) 335
amino acid sequence (333) 333
enzymes (329) 329
peptides (329) 329
brain (308) 308
cell biology (299) 299
amyloid beta-peptides - metabolism (291) 291
adolescent (285) 285
hematology (284) 284
neprilysin - biosynthesis (283) 283
enkephalinase (282) 282
hypertension (279) 279
glycopeptides - pharmacology (277) 277
antigens, neoplasm - analysis (275) 275
angiotensin (272) 272
blood pressure - drug effects (271) 271
heart-failure (269) 269
child (267) 267
flow cytometry (258) 258
cells, cultured (255) 255
analysis (253) 253
angiotensin-converting enzyme inhibitors - pharmacology (253) 253
diagnosis, differential (253) 253
kinetics (251) 251
alzheimers-disease (250) 250
dose-response relationship, drug (249) 249
enalapril (245) 245
substance-p (244) 244
neprilysin inhibition (242) 242
in vitro techniques (239) 239
neprilysin - physiology (237) 237
time factors (237) 237
research (235) 235
disease models, animal (232) 232
natriuretic peptides (232) 232
treatment outcome (225) 225
rats, sprague-dawley (224) 224
heart failure - physiopathology (223) 223
immunophenotyping (223) 223
a-beta (222) 222
gene expression (222) 222
biomarkers, tumor - analysis (221) 221
phenotype (218) 218
hydrolysis (217) 217
thiorphan - pharmacology (217) 217
peripheral vascular disease (215) 215
medicine, research & experimental (214) 214
peptide (214) 214
mortality (213) 213
endopeptidases - metabolism (212) 212
peptidyl-dipeptidase a - metabolism (210) 210
physiology (206) 206
cells (201) 201
tetrazoles - therapeutic use (199) 199
proteins (198) 198
angiotensin receptor antagonists - therapeutic use (195) 195
lcz696 (194) 194
inhibition (192) 192
aminobutyrates - therapeutic use (191) 191
research article (190) 190
cell line (187) 187
diagnosis (186) 186
child, preschool (184) 184
rats, wistar (181) 181
metabolism (180) 180
brain - metabolism (179) 179
abridged index medicus (176) 176
substrate specificity (173) 173
alzheimer disease - metabolism (172) 172
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5873) 5873
Chinese (112) 112
Japanese (94) 94
Russian (56) 56
French (53) 53
German (43) 43
Polish (18) 18
Spanish (15) 15
Portuguese (8) 8
Italian (7) 7
Czech (6) 6
Korean (5) 5
Croatian (2) 2
Hungarian (2) 2
Romanian (2) 2
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 06/2016, Volume 133, Issue 23, pp. 2254 - 2262
BACKGROUND—Many episodes of worsening of heart failure (HF) are treated by increasing oral therapy or temporary intravenous treatment in the community or... 
mortality | heart failure | hospitalization | neprilysin | emergency service, hospital | sacubitril/valsartan | NEPRILYSIN INHIBITION | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK | CARE | SUBSEQUENT MORTALITY | HOSPITAL READMISSION | EMERGENCY-DEPARTMENT | THERAPY | PERIPHERAL VASCULAR DISEASE | OUTCOMES | ENALAPRIL | INPATIENT | Angiotensin II Type 1 Receptor Blockers - adverse effects | Prospective Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Male | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Endpoint Determination | Protease Inhibitors - adverse effects | Female | Heart Failure - diagnosis | Protease Inhibitors - therapeutic use | Heart Failure - mortality | Double-Blind Method | Risk Assessment | Risk Factors | Treatment Outcome | Hospitalization | Neprilysin - metabolism | Ambulatory Care | Disease Progression | Neprilysin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Research Design | Heart failure | Care and treatment | Emergency service | Receptors | Hospitals | Analysis | Angiotensin | Comparative analysis | ACE inhibitors | Health aspects | Risk factors | hospital readmission | emergency-department | enalapril | inpatient | therapy | subsequent mortality | Kardiologi | Cardiac and Cardiovascular Systems | neprilysin inhibition | Cardiovascular System & Cardiology | outcomes | emergency service | risk | hospital | care
Journal Article
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 06/2017, Volume 69, Issue 6, pp. 374 - 381
Journal Article
European journal of heart failure, ISSN 1388-9842, 2013, Volume 15, Issue 9, pp. 1062 - 1073
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 09/2016, Volume 99, Issue 3, pp. 607 - 623
Journal Article
International journal of obesity (2005), ISSN 1476-5497, 2010, Volume 35, Issue 8, pp. 1031 - 1040
Journal Article
Journal Article